Table of Contents:
Pharmaceutical and cosmetic products
Outline of the Community (European Union) legislation about Pharmaceutical and cosmetic products
Topics
These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.
Internal market > Pharmaceutical and cosmetic products
Pharmaceutical and cosmetic products
The European pharmaceutical industry has an important role to play in ensuring that the people of Europe enjoy a good standard of health. The European Union strives, therefore, to guarantee broad access to medicinal products, to provide the public with high quality information, and to ensure that the medicinal products manufactured are safe and effective. The single market for pharmaceutical products makes it possible to achieve these aims by increasing the competitiveness of the industry through promoting research and innovation for the benefit of the public.
The European cosmetic industry is an important employer. 150 000 people work in the industry itself, and the sale, distribution and transport of cosmetics indirectly creates a further 350 000 jobs. With a production value of more than €35 billion, this innovative industry is a world leader in the field. The European Union aims to ensure free movement of cosmetic products in the internal market and to guarantee that the products are safe.
Single Market and the pharmaceutical industry
- A renewed vision for the pharmaceutical sector
- Parallel imports of proprietary medicinal products
- A call for action to strengthen the European-based pharmaceutical industry for the benefit of the patient
- IMI Joint Undertaking
Common provisions for medicines for human and veterinary use
- Authorisation and supervision of medicinal products – European Medicines Agency
- Good laboratory practice: tests on chemical substances
- Good laboratory practice: inspection and verification of laboratory studies on all chemicals
- Colouring matters for medicinal products (recast)
- Supplementary protection certificate for medicinal products
- Protection of laboratory animals
- European Pharmacopoeia
Medicinal products for human consumption
- Community code relating to medicinal products for human use
- Good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use
- Advanced therapy medicinal products
- Medicinal products for paediatric use
- Price of medicinal products for human use: pricing and health insurance
- Good clinical practice
- Orphan medicinal products
- Pharmaceutical Committee
Medicinal products for veterinary use
- Community code relating to veterinary medicinal products
- Good manufacturing practice for veterinary medicinal products
- Residues of veterinary medicinal products in foodstuffs of animal origin
- Preparation and marketing of medicated foodstuffs for animals
Cosmetic products
- Cosmetic products (from 2013)
- Cosmetic products (until 2013)
Patents and invention protection
- Community patent
- Legal protection of biotechnological inventions
- Patent law in the field of biotechnology and genetic engineering: implementation report (2002)
- Agreement on intellectual property rights relating to trade and pharmaceutical patents
Multilateral trade
- Essential medicines for developing countries (HIV/AIDS, tuberculosis and malaria)
- Compulsory licensing system for the production and export of generic medicinal products to developing countries
- Duty free treatment